Finance

Lists
CUP:FRA
Chugai Pharmaceutical Co Ltd
€ 40.48
+1.43%
(+0.57) 1D
11-р сарын 11, 09:55:01 (GMT+1)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CUP...
Open
€ 40.48
High
€ 40.48
Low
€ 40.48
Mkt. cap
12.00ИН
Avg. vol.
6.00
Volume
0.00
52-wk high
€ 56.26
52-wk low
€ 33.52
No. of employees
5 мян
Open
€ 40.48
High
€ 40.48
Low
€ 40.48
Mkt. cap
12.00ИН
Avg. vol.
6.00
Volume
0.00
52-wk high
€ 56.26
52-wk low
€ 33.52
No. of employees
5 мян
News stories
From web sources and news partners
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1 мян
Founded1925 оны 3-р сарын 10
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
346.30Т
321.75Т
341.58Т
404.74Т
Cost of goods sold
87.56 тэрбум
92.79 тэрбум
104.22Т
119.09Т
Cost of revenue
87.56 тэрбум
92.79 тэрбум
104.22Т
119.09Т
Research and development expenses
52.41 тэрбум
41.89 тэрбум
47.76 тэрбум
49.89 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.92 тэрбум
28.90 тэрбум
29.04 тэрбум
32.37 тэрбум
Operating expense
89.74 тэрбум
70.19 тэрбум
76.51 тэрбум
82.70 тэрбум
Total operating expenses
177.30Т
162.98Т
180.73Т
201.80Т
Operating income
169.01Т
158.76Т
160.86Т
202.95Т
Other non operating income
994.00 сая
1.43 тэрбум
3.04 тэрбум
1.74 тэрбум
EBT including unusual items
169.90Т
160.20Т
169.02Т
204.68Т
EBT excluding unusual items
169.90Т
160.20Т
169.02Т
204.68Т
Income tax expense
41.50 тэрбум
44.78 тэрбум
52.69 тэрбум
61.13 тэрбум
Effective tax rate
24.42%
27.95%
31.17%
29.87%
Other operating expenses
405.00 сая
-596.00 сая
-291.00 сая
446.00 сая
Net income
128.41Т
115.42Т
116.33Т
143.55Т
Net profit margin
37.08%
35.87%
34.06%
35.47%
Earnings per share
-
-
-
-
Interest and investment income
-
-
5.13 тэрбум
-
Interest expense
-95.00 сая
-
-
-
Net interest expenses
-95.00 сая
-
5.13 тэрбум
-
Depreciation and amortization charges
-
-
-
-
EBITDA
200.44Т
159.26Т
161.56Т
203.65Т
Gain or loss from assets sale
4.53 тэрбум
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google аппс